good timing was on PAR's side when I did that large $$$ raising in 2019. I think they still have $70+M to take them through all the FDA process. Smart move. This reduces their risks for 2020. if this upheaval goes on beyond 2020 then it might be different. Hold the faith. PAR is better placed than most bio companies at this point in time. Market Cap looks cheap at these levels.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
43.0¢ |
Change
0.010(2.38%) |
Mkt cap ! $170.8M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.5¢ | 41.5¢ | $243.2K | 572.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7058 | 42.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 16117 | 1 |
View Market Depth
| Last trade - 16.10pm 23/07/2025 (20 minute delay) ? |
| PAR (ASX) Chart |